These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8485812)

  • 21. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy.
    Ali-Osman F; Berger MS; Rairkar A; Stein DE
    J Cell Biochem; 1994 Jan; 54(1):11-9. PubMed ID: 8126081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT; Vaisman A; Chaney SG; Sancar A
    Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.
    Damia G; Imperatori L; Citti L; Mariani L; D'Incalci M
    Br J Cancer; 1996 Apr; 73(7):861-5. PubMed ID: 8611396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination.
    Keller KL; Overbeck-Carrick TL; Beck DJ
    Mutat Res; 2001 Jun; 486(1):21-9. PubMed ID: 11356333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic screening in vivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatin.
    Liao C; Hu B; Arno MJ; Panaretou B
    Mol Pharmacol; 2007 Feb; 71(2):416-25. PubMed ID: 17093137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: cisplatin and mitomycin C in cultured Vero cells.
    Rjiba-Touati K; Ayed-Boussema I; Soualeh N; Achour A; Bacha H; Abid S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):943-50. PubMed ID: 23970409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA excision-repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatin.
    Calsou P; Barret JM; Cros S; Salles B
    Eur J Biochem; 1993 Feb; 211(3):403-9. PubMed ID: 8436104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution.
    Hu J; Lieb JD; Sancar A; Adar S
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11507-11512. PubMed ID: 27688757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in repair of alkylating agent-induced DNA damage in polyamine-depleted human cells.
    Snyder RD; Bhatt S
    Cancer Lett; 1993 Aug; 72(1-2):83-90. PubMed ID: 8402580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs.
    Alaoui-Jamali M; Loubaba BB; Robyn S; Tapiero H; Batist G
    Cancer Chemother Pharmacol; 1994; 34(2):153-8. PubMed ID: 8194166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A mechanism of cisplatin resistance in a cisplatin resistant lung cancer cell line].
    Bungo M; Nakagawa K; Saijo N
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):515-6. PubMed ID: 2321980
    [No Abstract]   [Full Text] [Related]  

  • 35. DNA REPAIR. Drugging DNA repair.
    Jackson SP; Helleday T
    Science; 2016 Jun; 352(6290):1178-9. PubMed ID: 27257245
    [No Abstract]   [Full Text] [Related]  

  • 36. DNA repair pathways and cisplatin resistance: an intimate relationship.
    Rocha CRR; Silva MM; Quinet A; Cabral-Neto JB; Menck CFM
    Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e478s. PubMed ID: 30208165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of point mutations in T lymphocytes.
    van Zeeland AA; Jansen JG; Mohn GR; Vrieling H; Tates AD; Lohman PH
    Clin Chem; 1995 Dec; 41(12 Pt 2):1841-3. PubMed ID: 7497642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of H2AX phosphorylation after exposure to cisplatin.
    Olive PL; Banáth JP
    Cytometry B Clin Cytom; 2009 Mar; 76(2):79-90. PubMed ID: 18727058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of resistance to cisplatin.
    Eastman A
    Cancer Treat Res; 1991; 57():233-49. PubMed ID: 1686719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.